Literature DB >> 25532864

The D3 dopamine receptor: From structural interactions to function.

Chiara Fiorentini1, Paola Savoia2, Federica Bono2, Paola Tallarico2, Cristina Missale2.   

Abstract

Novel structural and functional aspects of the dopamine (DA) D3 receptors (D3R) have been recently described. D3R expressed in dopaminergic neurons have been classically considered to play the role of autoreceptors inhibiting, as the D2R, DA release. However, evidence for D3R-mediated neurotrophic and neuroprotective effects on DA neurons suggests their involvement in preventing pathological alterations leading to neurodegeneration. On the other hand, given its localization and functional role at postsynaptic striatal levels, the D3R may also be involved in the pathogenesis of movement disorders and psychiatric diseases. Functional interactions of D3R with other receptor systems are crucial for the modulation of several physiological events. On this line, the discovery that the D3R can form heteromers with other receptors has opened the possibility of uncover novel molecular mechanisms of brain functions and dysfunctions. This paper summarizes the functional and physical interactions of D3R with other receptors both at pre-synaptic sites, where it is co-expressed with the D2R and nicotinic receptors, and at post-synaptic sites where it interacts with the DA D1 receptors (D1R). The biochemical and functional properties of the D1R-D3R heteromer will be especially discussed. Both D1R and D3R have been in fact implicated in several disorders, including schizophrenia and motor dysfunctions. Therefore, the D1R-D3R heteromer may represent a potential drug target for the treatment of these diseases.
Copyright © 2014 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Heterodimerization; L-DOPA-induced dyskinesia; Neurodegeneration

Mesh:

Substances:

Year:  2014        PMID: 25532864     DOI: 10.1016/j.euroneuro.2014.11.021

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  14 in total

1.  Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.

Authors:  Fernando Caravaggio; Enzo Scifo; Etienne L Sibille; Sergio E Hernandez-Da Mota; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero
Journal:  Exp Eye Res       Date:  2018-06-05       Impact factor: 3.467

2.  Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Authors:  Federica Bono; Paola Savoia; Adele Guglielmi; Massimo Gennarelli; Giovanna Piovani; Sandra Sigala; Damiana Leo; Stefano Espinoza; Raul R Gainetdinov; Paola Devoto; PierFranco Spano; Cristina Missale; Chiara Fiorentini
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

Review 3.  Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?

Authors:  Rosa M Villalba; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-05-24       Impact factor: 3.575

4.  Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists.

Authors:  Wei Xu; Xiaozhao Wang; Aaron M Tocker; Peng Huang; Maarten E A Reith; Lee-Yuan Liu-Chen; Amos B Smith; Sandhya Kortagere
Journal:  ACS Chem Neurosci       Date:  2016-11-23       Impact factor: 4.418

5.  Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.

Authors:  Kathryn Lanza; Katherine Chemakin; Sarah Lefkowitz; Carolyn Saito; Nicole Chambers; Christopher Bishop
Journal:  Psychopharmacology (Berl)       Date:  2019-08-21       Impact factor: 4.530

6.  Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.

Authors:  Edward C Gaiser; Jean-Dominique Gallezot; Patrick D Worhunsky; Ania M Jastreboff; Brian Pittman; Lauren Kantrovitz; Gustavo A Angarita; Kelly P Cosgrove; Marc N Potenza; Robert T Malison; Richard E Carson; David Matuskey
Journal:  Neuropsychopharmacology       Date:  2016-07-04       Impact factor: 7.853

Review 7.  Dopamine receptors: homomeric and heteromeric complexes in L-DOPA-induced dyskinesia.

Authors:  Oscar Solís; Rosario Moratalla
Journal:  J Neural Transm (Vienna)       Date:  2018-02-07       Impact factor: 3.575

8.  Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Authors:  Thomas M Keck; William S John; Paul W Czoty; Michael A Nader; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-03-31       Impact factor: 7.446

9.  Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons.

Authors:  Federica Bono; Chiara Fiorentini
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

10.  The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.

Authors:  Jing Wang; Yuwei Jia; Guodong Li; Biao Wang; Ting Zhou; Li Zhu; Teng Chen; Yanjiong Chen
Journal:  Int J Neuropsychopharmacol       Date:  2018-05-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.